Tus kws kho mob
QP43-18 Addition of Drugs to the Oral Immunotherapy PA with QL Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 06, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2981 - 2990 ntawm 3669
Tus kws kho mob
QP56-18 Availity Authorization Portal Update
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 18, 2018
Tus kws kho mob
QP28-16 Reminders for Providers who Provide Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2016
Tus kws kho mob
QP19-16 Incomplete Information on Post Service Appeals
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 26, 2016
Tus kws kho mob
QP35-16 Update: Change to Apogee Employer Group
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2016
Tus kws kho mob
QP48-18 Referral Create, Inquiry and Update Functions Available on Availity
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2018
Tus kws kho mob
QP25-17 Pharmacy Benefit Exclusion
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 06, 2017
Tus kws kho mob
QP46-17 Better Care through Quality Improvement
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 07, 2017
Tus kws kho mob
QP38-18 Learning Environment for Risk Adjustment and Value Based Topics
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2018
Tus kws kho mob
QP25-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Samsca (tolvaptan)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 19, 2018